Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Multicenter Prospective Randomized Trial of the Effect of Rivaroxaban on Survival and Development of Complications of Portal Hypertension in Patients With Cirrhosis (CIRROXABAN)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02643212
Recruitment Status : Recruiting
First Posted : December 31, 2015
Last Update Posted : April 25, 2018
Sponsor:
Collaborator:
IDIBAPS - Dr. Juan Carlos García Pagán
Information provided by (Responsible Party):
David Garcia Cinca, Hospital Clinic of Barcelona

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 2019
Estimated Study Completion Date : December 2019